Last checked at 12 Dec 2023 16:13
12 December 2023
LEI: 635400TLVVBNXLFHWC59
KERRY GROUP
Kerry to acquire Lactase Enzymes Business
Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes") (together the "Lactase Enzymes Business") on a carve out basis¹. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.
The Lactase Enzymes Business which includes NOLA® Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex². This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste. Global demand for lactase is being driven by increased awareness of lactose intolerance, while many consumers are also choosing lactose-free for lifestyle and health reasons.
The Lactase Enzymes Business had attributable revenue of approximately ?40m in 2022 with sales in over 50 countries. Total consideration is ?150m subject to routine closing adjustments, with the acquisition expected to close in the first half of 2024.
¹ Acquisition comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and 100% of the share capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese subsidiary of Novozymes.
² Acquisition of c-LEcta GmbH completed in March 2022 and Enmex S.A. de C.V. in December 2021.
ENDS
About Kerry
Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.
| CONTACT INFORMATION |
|
Investor Relations | ||
Marguerite Larkin, Chief Financial Officer | ||
+353 66 7182292 | investorrelations@kerry.ie | ||
|
| |
William Lynch, Head of Investor Relations | ||
+353 66 7182292 | investorrelations@kerry.ie | ||
| ||
Media | ||
| Catherine Keogh, Chief Corporate Affairs & Brand Officer |
|
+353 45 930188 | corpaffairs@kerry.com | ||
Website | ||
| www.kerry.com |
|